Product Program year 2021 Source: CMS Open Payments

LifeSPARC System

Device Cardiology/Vascular Diseases

PDI 814112020593

Open in the dashboard

General payments

$44,151

400 payments

Research payments

$0

0 payments

Through program year 2021, $44,151 in general payments and $0 in research payments were reported against LifeSPARC System (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $44,151 400

Breakdown

Who paid General payments · program year 2021
  1. LivaNova USA, Inc. $44,151 400 payments
Top recipients General payments · program year 2021
  1. Karl Kern Cardiovascular Disease · Tucson, AZ $9,434 21% · 4 payments
  2. David Baran Advanced Heart Failure and Transplant Cardiology · Weston, FL $7,606 17% · 7 payments
  3. Rajan Patel Interventional Cardiology · New Orleans, LA $3,560 8% · 1 payment
  4. Eric Gnall Interventional Cardiology · Wynnewood, PA $1,542 3% · 4 payments
  5. Anton Lishmanov Cardiovascular Disease · Hudson, FL $1,160 3% · 11 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $13,196 30% · 38 practitioners
  2. Interventional Cardiology Internal Medicine $10,656 24% · 83 practitioners
  3. Advanced Heart Failure and Transplant Cardiology Internal Medicine $8,150 19% · 14 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,926 9% · 50 practitioners
  5. Critical Care Medicine Internal Medicine $1,036 2% · 18 practitioners

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Arizona $10,605 24% · 11 recipients
  2. Virginia $7,864 18% · 11 recipients
  3. Louisiana $3,624 8% · 2 recipients
  4. Pennsylvania $3,338 8% · 33 recipients
  5. Texas $2,814 6% · 23 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

400 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record